Cargando…
Overexpressed methyltransferase-like 1 (METTL1) increased chemosensitivity of colon cancer cells to cisplatin by regulating miR-149-3p/S100A4/p53 axis
Methyltransferase-like 1 (METTL1) mediated 7-methylguanosine (m7G) is crucial for the regulation of chemoresistance in cancer treatment. However, the role of METTL1 in regulating chemoresistance of colon cancer (CC) cells to cisplatin is still unclear. This study established the cisplatin-resistant...
Autores principales: | Liu, Yang, Yang, Chunyan, Zhao, Yong, Chi, Qiang, Wang, Zhen, Sun, Boshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6949057/ https://www.ncbi.nlm.nih.gov/pubmed/31866582 http://dx.doi.org/10.18632/aging.102575 |
Ejemplares similares
-
Metformin-induced chemosensitization to cisplatin depends on P53 status and is inhibited by Jarid1b overexpression in non-small cell lung cancer cells
por: Tortelli, Tharcisio Citrangulo, et al.
Publicado: (2021) -
Dichloroacetate restores colorectal cancer chemosensitivity through the p53/miR-149-3p/PDK2-mediated glucose metabolic pathway
por: Liang, Yu, et al.
Publicado: (2019) -
DNA methyltransferase 3a modulates chemosensitivity to gemcitabine and oxaliplatin via CHK1 and AKT in p53-deficient pancreatic cancer cells
por: Jing, Wei, et al.
Publicado: (2018) -
Co-expression of ING4 and P53 enhances hypopharyngeal cancer chemosensitivity to cisplatin in vivo
por: Ren, Xin, et al.
Publicado: (2016) -
Blockade of TRIM59 enhances esophageal cancer cell chemosensitivity to cisplatin by upregulating p53
por: Liu, Rongfeng, et al.
Publicado: (2021)